Connection
David Wagner to Inflammation
This is a "connection" page, showing publications David Wagner has written about Inflammation.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.597 |
|
|
|
-
Vaitaitis GM, Waid DM, Sharkey C, Sharkey S, Webb TL, Webb C, Wagner DH. A CD40-targeting peptide, OPT501, modulates inflammation in canine diabetes mellitus improving clinical outcomes. Front Immunol. 2026; 17:1759373.
Score: 0.422
-
Vaitaitis G, Webb T, Webb C, Sharkey C, Sharkey S, Waid D, Wagner DH. Canine diabetes mellitus demonstrates multiple markers of chronic inflammation including Th40 cell increases and elevated systemic-immune inflammation index, consistent with autoimmune dysregulation. Front Immunol. 2023; 14:1319947.
Score: 0.091
-
Curran C, Vaitaitis G, Waid D, Volmer T, Alverez E, Wagner DH. Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS). J Neuroimmunol. 2023 Jan 15; 374:578008.
Score: 0.084